Sjogren Syndrome

Populations and Risk Factors

• Women affected approximately 9:1 over men; most commonly diagnosed between ages 40 and 60
• Primary Sjogren syndrome: occurs independently without another autoimmune condition; affects approximately 60% of Sjogren patients
• Secondary Sjogren syndrome: occurs alongside RA (most common), SLE, scleroderma, or polymyositis — the co-existing condition determines additional treatment modifications
• Genetic predisposition: HLA-DR3 and HLA-B8 associations; familial clustering of autoimmune diseases
• Environmental triggers: viral infections (Epstein-Barr virus, hepatitis C) hypothesized as initiating events in genetically susceptible individuals
• 5–10% lifetime risk of developing non-Hodgkin B-cell lymphoma — the most serious complication, arising from chronic B-cell hyperactivation
• Frequently overlaps with fibromyalgia (30–50%), which compounds the myalgia and fatigue burden

Causes and Pathophysiology

Glandular Destruction

• Autoimmune targeting of exocrine glands: Autoreactive T-cells (primarily CD4+) infiltrate the salivary and lacrimal glands, forming organized lymphocytic clusters (focal lymphocytic sialadenitis). These lymphocytes, along with autoantibodies (anti-Ro/SSA and anti-La/SSB), progressively destroy the glandular acinar cells that produce saliva and tears. The destruction is gradual and cumulative — by the time sicca symptoms become clinically apparent, significant glandular architecture has already been lost.
• Anti-Ro/SSA and anti-La/SSB antibodies: These autoantibodies target intracellular ribonucleoprotein complexes. Anti-Ro/SSA is found in 60–80% of primary Sjogren patients and anti-La/SSB in 30–50%. Their presence correlates with earlier onset, more severe glandular destruction, and higher risk of extraglandular manifestations. Anti-Ro/SSA can cross the placenta and cause neonatal lupus with congenital heart block.
• Mucosa-associated lymphoid tissue (MALT) expansion: The persistent lymphocytic infiltration of the salivary glands creates ectopic lymphoid structures (MALT). Over years, chronic B-cell stimulation within these structures can undergo malignant transformation — this is the mechanism behind the 5–10% lymphoma risk. Persistent or progressive parotid gland enlargement is the most concerning clinical sign.

Extraglandular Manifestations — The "Beyond Dryness" Burden

• Arthralgia and arthritis (50–70%): Sjogren syndrome produces a non-erosive, non-deforming inflammatory arthritis similar to SLE — synovial inflammation from autoantibody-mediated immune complex deposition. The joints most commonly affected are the MCPs, PIPs, wrists, and knees. Unlike RA, the arthritis does not produce pannus or erosive destruction, and unlike SLE, Jaccoud arthropathy is uncommon. The arthralgia is often the presenting complaint before sicca symptoms become prominent.
• Myalgia (50–75%): Widespread muscle pain from low-grade inflammatory myopathy (immune complex deposition in muscle microvasculature) and central sensitization. True inflammatory myositis (elevated CK, proximal weakness) is uncommon (<5%); the myalgia more closely resembles the pain of fibromyalgia — diffuse, variable, and worsened by fatigue. The significant overlap with fibromyalgia (30–50%) makes it clinically challenging to distinguish disease-related myalgia from coexisting fibromyalgia.
• Fatigue (up to 70%): Profound fatigue disproportionate to activity — driven by chronic immune activation (elevated cytokines), autonomic dysfunction, and poor sleep quality from sicca-related discomfort (dry mouth disrupts sleep, eye irritation causes frequent waking). Fatigue is often rated by patients as more disabling than dryness.
• Peripheral neuropathy (10–20%): Small-fiber neuropathy is most common, producing burning, tingling, or numbness in a stocking-glove distribution; less commonly, cranial neuropathies (trigeminal sensory neuropathy producing facial numbness) and autonomic neuropathy occur. The mechanism is vasculitis of the vasa nervorum (blood vessels supplying the nerves). Neuropathy findings on palpation must be distinguished from compression neuropathies.
• Raynaud phenomenon (15–30%): Secondary Raynaud from immune-mediated endothelial injury — same mechanism as in SLE. Produces episodic digital vasospasm triggered by cold or stress, requiring warm treatment environment and avoidance of cold applications.

Skin and Mucosal Involvement

• Cutaneous dryness: Destruction of eccrine sweat glands and sebaceous glands by the same lymphocytic infiltration that targets salivary and lacrimal glands produces widespread, chronic skin dryness — this directly affects massage therapy because dry skin is more susceptible to friction injury, irritant reaction, and allergic sensitization. The dryness is systemic, not localized.
• Vaginal dryness: Destruction of Bartholin's glands and vaginal mucosal atrophy from reduced moisture — relevant for informed consent and positioning comfort.
• Nasal and respiratory dryness: Dry nasal passages, dry cough from reduced respiratory mucosal moisture, and increased susceptibility to respiratory infections.

Signs and Symptoms

Sicca Symptoms

• Keratoconjunctivitis sicca: Dry, gritty, burning eyes with foreign body sensation ("sand in the eyes"); light sensitivity (photophobia); redness; increased susceptibility to corneal abrasion and infection; difficulty wearing contact lenses; symptoms worsen in dry or air-conditioned environments
• Xerostomia: Severe dry mouth with difficulty swallowing dry foods, speaking for prolonged periods, and altered taste; dramatically increased dental caries (saliva normally provides antimicrobial and remineralizing protection); oral candidiasis (thrush) from disrupted oral microbiome; dry, cracked lips; difficulty wearing dentures
• Parotid gland enlargement (episodic or persistent) — bilateral, non-tender swelling of the parotid glands; persistent unilateral enlargement is a red flag for lymphoma

Musculoskeletal Presentation

• Arthralgia and/or non-erosive arthritis — bilateral, symmetric, affecting small to medium joints (MCPs, PIPs, wrists, knees); may be the presenting complaint
• Widespread myalgia — diffuse, variable, fluctuating with disease activity and fatigue level; resembles fibromyalgia pattern
• Fatigue — profound, disproportionate to activity, often rated as the most disabling symptom
• Peripheral neuropathy — burning, tingling, or numbness in hands and feet (stocking-glove pattern); may include facial numbness (trigeminal sensory neuropathy)
• Raynaud phenomenon — episodic digital color changes (white-blue-red) triggered by cold or stress

Systemic Features

• Low-grade fever and malaise during disease flares
• Purpura (small vessel vasculitis) — non-blanching reddish-purple spots on the skin, particularly lower extremities
• Interstitial lung disease (dry cough, dyspnea on exertion)
• Renal tubular acidosis (rare but clinically significant)
• Cognitive dysfunction ("brain fog") — similar to SLE
• Lymphadenopathy — generalized or regional; persistent, hard, fixed lymph node enlargement requires lymphoma evaluation

Assessment Profile

Subjective Presentation

• Chief complaint: "My eyes are always dry and gritty, and my mouth is so dry I have to sip water constantly. But honestly, the joint aches and the exhaustion bother me even more." Patients often present initially with sicca symptoms, but on questioning, the musculoskeletal and fatigue burden emerges as equally or more disabling. Some patients present with arthralgia before dryness symptoms are recognized.
• Pain quality: Diffuse, aching muscle pain fluctuating with fatigue levels; bilateral joint aching without sharp inflammatory quality; burning or tingling in hands and feet if neuropathy is present; eye discomfort described as "gritty," "sandy," or "burning" rather than as pain
• Onset: Insidious over months to years; sicca symptoms develop gradually and are often initially attributed to aging, medications, or environmental factors; musculoskeletal symptoms may precede or accompany dryness; diagnosis often delayed years after symptom onset
• Aggravating factors: Dry environments (air conditioning, heating, airplane travel), reading or screen time (reduced blink rate worsens eye dryness), prolonged speaking or eating dry foods, cold (triggers Raynaud), fatigue, stress, dehydration
• Easing factors: Artificial tears and saliva substitutes, frequent water sipping, humidity, rest, warmth (for Raynaud and joint stiffness), hydroxychloroquine (Plaquenil) for joint symptoms and fatigue
• Red flags: Persistent unilateral parotid gland enlargement → lymphoma screening required; persistent hard, fixed lymph node enlargement → lymphoma screening required; new neurological deficit (weakness, numbness, cranial nerve dysfunction) → neurology referral for vasculitis or CNS involvement; purpura with systemic symptoms → vasculitis evaluation

Observation

• Local inspection: Dry, cracked lips; reduced saliva pooling under the tongue; bilateral parotid gland enlargement (visible as fullness anterior to the ears and below the zygomatic arch); dry skin (may appear flakey or dull); redness and irritation of the eyes; no joint swelling or deformity typically visible (unlike RA); digital color changes if Raynaud is present; purpura on lower extremities if vasculitis is active
• Posture: Compensatory postural patterns from chronic fatigue and deconditioning (forward head, increased kyphosis, shoulder protraction) — similar to CFS/ME and lupus patterns; protective guarding of affected joints; overall postural deterioration proportional to disease duration and fatigue severity
• Gait: Generally normal; may show stiffness from joint involvement; cautious or slow gait from fatigue and deconditioning; neuropathic gait pattern (wide-based, cautious foot placement) if significant peripheral neuropathy is present

Palpation

• Tone: Compensatory hypertonicity in upper trapezius, cervical extensors, and shoulder girdle from chronic fatigue posture and pain guarding; diffuse tenderness without the specific trigger point pattern of myofascial pain syndrome; tone changes are typically bilateral reflecting the systemic nature of the condition; if fibromyalgia coexists, specific tender point findings will be superimposed on the diffuse pattern
• Tenderness: Bilateral parotid gland tenderness (palpable as soft, diffuse enlargement anterior to the ears — distinguish from hard, fixed lymph node enlargement which is a red flag); bilateral joint line tenderness in affected joints (MCPs, PIPs, wrists, knees) — mild boggy quality similar to SLE rather than the pronounced synovial thickening of RA; diffuse muscle tenderness — widespread and variable rather than localized; cervical and axillary lymph nodes may be mildly tender; peripheral neuropathy produces positive Tinel's sign or allodynia in affected regions
• Temperature: No significant joint warmth in most cases (inflammation is mild compared to RA); digits may be cool if Raynaud is present; normal skin temperature otherwise; dry skin feels rougher and less supple than normal on palpation
• Tissue quality: Skin is notably dry — reduced elasticity, flakey texture, more susceptible to friction; subcutaneous tissue may feel thin in chronic disease with corticosteroid use; no specific fibrotic changes; parotid glands palpable as firm but compressible bilateral enlargements; generalized reduced muscle bulk from deconditioning and fatigue-related inactivity; in patients with secondary Sjogren (RA or scleroderma), tissue findings of the primary condition will be superimposed

Motion Assessment

• AROM: Mildly reduced in affected joints during arthritis flares — MCPs, PIPs, wrists, knees; less severe than RA; grip strength reduced but typically better than RA patients at equivalent disease duration; cervical AROM may be reduced from fatigue-related postural tension; generalized movement limited more by fatigue than by specific joint restriction
• PROM / end-feel: PROM exceeds AROM in affected joints (pain inhibition rather than capsular restriction); end-feel is guarded/protective during flares, normal at other times; no capsular pattern restriction (distinguishes from adhesive capsulitis); if secondary to RA, capsular findings of RA will be present in addition
• Resisted testing: Mild pain on resisted testing of actively inflamed joints; weakness is from deconditioning rather than specific myotomal pattern; grip strength bilaterally reduced; if true proximal weakness with elevated CK is present, inflammatory myositis should be investigated

Special Test Cluster

Note: If the patient has secondary Sjogren with RA or scleroderma, add the condition-specific SOT cluster for that primary condition. If neuropathy symptoms include facial numbness, cranial nerve assessment is indicated.

Differential Diagnoses